(QDEL) Quidel - Ratings and Ratios
Diagnostic, Test, Kits
QDEL EPS (Earnings per Share)
QDEL Revenue
Description: QDEL Quidel August 13, 2025
Quidel Corporation (QDEL) is a healthcare supplies company listed on NASDAQ, operating in the United States. The companys quarterly tax provision is a critical aspect of its financials, influencing its overall profitability and cash flow.
Analyzing QDELs market performance, we observe a significant decline in its stock price over the past year, with a 52-week high of $47.61 and a low of $22.81. The current price is near the 52-week low, indicating potential undervaluation. The Average True Range (ATR) of 1.32, representing 5.56% of the current price, suggests moderate volatility.
From a fundamental analysis perspective, QDELs Market Capitalization stands at $1.656 billion, with a forward Price-to-Earnings (P/E) ratio of 10.64, indicating the markets expectations for future earnings growth. The Return on Equity (RoE) is negative, at -15.60%, suggesting that the company is currently unprofitable. Key drivers for QDELs financial performance include demand for its healthcare supplies products, competition in the market, and the companys ability to manage its costs and tax provisions effectively.
To evaluate QDELs potential, we should monitor Key Performance Indicators (KPIs) such as revenue growth, gross margin, operating expenses as a percentage of revenue, and cash flow generation. Economic drivers that could impact QDELs performance include changes in healthcare policies, technological advancements in medical diagnostics, and shifts in global demand for healthcare supplies.
A thorough analysis of QDELs quarterly tax provision and its impact on the companys financials is essential. We need to assess the companys tax strategy, potential tax liabilities, and opportunities for tax savings. By understanding these factors, we can better evaluate QDELs profitability and potential for future growth.
QDEL Stock Overview
| Market Cap in USD | 1,930m |
| Sub-Industry | Health Care Supplies |
| IPO / Inception | 1991-02-01 |
QDEL Stock Ratings
| Growth Rating | -83.0% |
| Fundamental | 28.3% |
| Dividend Rating | - |
| Return 12m vs S&P 500 | -33.3% |
| Analyst Rating | 3.88 of 5 |
QDEL Dividends
Currently no dividends paidQDEL Growth Ratios
| Growth Correlation 3m | 68.3% |
| Growth Correlation 12m | -77.2% |
| Growth Correlation 5y | -96.8% |
| CAGR 5y | -30.19% |
| CAGR/Max DD 3y (Calmar Ratio) | -0.39 |
| CAGR/Mean DD 3y (Pain Ratio) | -0.71 |
| Sharpe Ratio 12m | -1.10 |
| Alpha | -30.82 |
| Beta | 0.268 |
| Volatility | 46.24% |
| Current Volume | 1003.4k |
| Average Volume 20d | 1123.3k |
| Stop Loss | 28.8 (-5.6%) |
| Signal | -0.30 |
Piotroski VR‑10 (Strict, 0-10) 3.0
| Net Income (-466.4m TTM) > 0 and > 6% of Revenue (6% = 164.6m TTM) |
| FCFTA 0.02 (>2.0%) and ΔFCFTA 4.48pp (YES ≥ +1.0pp, WARN ≥ +0.5pp) |
| NWC/Revenue 5.08% (prev 14.44%; Δ -9.35pp) (YES ≤20% & Δ≤-1pp; WARN ≤25% & Δ≤0 oder ≤40% & Δ≤-3pp) |
| CFO/TA 0.03 (>3.0%) and CFO 200.4m > Net Income -466.4m (YES >=105%, WARN >=100%) |
| Net Debt (2.67b) to EBITDA (222.7m) ratio: 11.99 <= 3.0 (WARN <= 3.5) |
| Current Ratio 1.12 (target 1.5–3.0; WARN 1.2–<1.5 or >3.0–5.0; CFO/TA gate active) |
| Outstanding Shares last Quarter (67.7m) change vs 12m ago 0.89% (target <= -2.0% for YES) |
| Gross Margin 56.57% (prev 41.99%; Δ 14.58pp) >=18% & Δ>=+0.5pp (WARN >=15% & Δ>=0) |
| Asset Turnover 41.98% (prev 42.35%; Δ -0.37pp) >=50% & Δ>=+2pp (WARN >=35% & Δ>=0) |
| Interest Coverage Ratio -1.19 (EBITDA TTM 222.7m / Interest Expense TTM 183.0m) >= 6 (WARN >= 3) |
Altman Z'' -0.18
| (A) 0.02 = (Total Current Assets 1.28b - Total Current Liabilities 1.14b) / Total Assets 6.38b |
| (B) -0.02 = Retained Earnings (Balance) -132.3m / Total Assets 6.38b |
| (C) -0.03 = EBIT TTM -217.1m / Avg Total Assets 6.53b |
| (D) -0.03 = Book Value of Equity -116.0m / Total Liabilities 3.59b |
| Total Rating: -0.18 = (6.56 * A) + (3.26 * B) + (6.72 * C) + (1.05 * D) |
ValueRay F-Score (Strict, 0-100) 28.34
| 1. Piotroski 3.0pt = -2.0 |
| 2. FCF Yield 2.68% = 1.34 |
| 3. FCF Margin 4.50% = 1.12 |
| 4. Debt/Equity 1.01 = 2.01 |
| 5. Debt/Ebitda 11.99 = -2.50 |
| 6. ROIC - WACC (= -8.29)% = -10.37 |
| 7. RoE -15.60% = -2.50 |
| 8. Rev. Trend -73.14% = -5.49 |
| 9. EPS Trend -65.74% = -3.29 |
What is the price of QDEL shares?
Over the past week, the price has changed by +5.21%, over one month by +7.70%, over three months by +16.94% and over the past year by -21.22%.
Is Quidel a good stock to buy?
Based on momentum, paid dividends and discounted-cash-flow analyses, the fair value of QDEL is around 23.28 USD . This means that QDEL is currently overvalued and has a potential downside of -23.7%.
Is QDEL a buy, sell or hold?
- Strong Buy: 3
- Buy: 2
- Hold: 2
- Sell: 1
- Strong Sell: 0
What are the forecasts/targets for the QDEL price?
| Issuer | Target | Up/Down from current |
|---|---|---|
| Wallstreet Target Price | 39.2 | 28.4% |
| Analysts Target Price | 39.2 | 28.4% |
| ValueRay Target Price | 24.9 | -18.4% |
QDEL Fundamental Data Overview October 18, 2025
P/E Forward = 9.5877
P/S = 0.7039
P/B = 0.7763
P/EG = 7.19
Beta = 0.268
Revenue TTM = 2.74b USD
EBIT TTM = -217.1m USD
EBITDA TTM = 222.7m USD
Long Term Debt = 2.07b USD (from longTermDebt, last quarter)
Short Term Debt = 564.2m USD (from shortTermDebt, last quarter)
Debt = 2.82b USD (from shortLongTermDebtTotal, last quarter)
Net Debt = 2.67b USD (from netDebt column, last quarter)
Enterprise Value = 4.60b USD (1.93b + Debt 2.82b - CCE 151.7m)
Interest Coverage Ratio = -1.19 (Ebit TTM -217.1m / Interest Expense TTM 183.0m)
FCF Yield = 2.68% (FCF TTM 123.3m / Enterprise Value 4.60b)
FCF Margin = 4.50% (FCF TTM 123.3m / Revenue TTM 2.74b)
Net Margin = -17.00% (Net Income TTM -466.4m / Revenue TTM 2.74b)
Gross Margin = 56.57% ((Revenue TTM 2.74b - Cost of Revenue TTM 1.19b) / Revenue TTM)
Gross Margin QoQ = 37.12% (prev 93.07%)
Tobins Q-Ratio = 0.72 (Enterprise Value 4.60b / Total Assets 6.38b)
Interest Expense / Debt = 1.63% (Interest Expense 46.1m / Debt 2.82b)
Taxrate = -11.24% (negative due to tax credits) (25.8m / -229.6m)
NOPAT = -241.5m (EBIT -217.1m * (1 - -11.24%)) [loss with tax shield] [negative tax rate / tax credits]
Current Ratio = 1.12 (Total Current Assets 1.28b / Total Current Liabilities 1.14b)
Debt / Equity = 1.01 (Debt 2.82b / totalStockholderEquity, last quarter 2.79b)
Debt / EBITDA = 11.99 (Net Debt 2.67b / EBITDA 222.7m)
Debt / FCF = 21.66 (Net Debt 2.67b / FCF TTM 123.3m)
Total Stockholder Equity = 2.99b (last 4 quarters mean from totalStockholderEquity)
RoA = -7.31% (Net Income -466.4m / Total Assets 6.38b)
RoE = -15.60% (Net Income TTM -466.4m / Total Stockholder Equity 2.99b)
RoCE = -4.29% (EBIT -217.1m / Capital Employed (Equity 2.99b + L.T.Debt 2.07b))
RoIC = -4.37% (negative operating profit) (NOPAT -241.5m / Invested Capital 5.53b)
WACC = 3.92% (E(1.93b)/V(4.75b) * Re(7.0%) + D(2.82b)/V(4.75b) * Rd(1.63%) * (1-Tc(-0.11)))
Discount Rate = 7.0% (= CAPM, Blume Beta Adj.) -> floored to rf + 0.7*ERP = 8.05%
Shares Correlation 3-Years: 33.33 | Cagr: 0.30%
[DCF Debug] Terminal Value 70.46% ; FCFE base≈123.3m ; Y1≈81.0m ; Y5≈37.0m
Fair Price DCF = 10.72 (DCF Value 727.7m / Shares Outstanding 67.9m; 5y FCF grow -40.0% → 3.0% )
EPS Correlation: -65.74 | EPS CAGR: -61.40% | SUE: -1.22 | # QB: 0
Revenue Correlation: -73.14 | Revenue CAGR: -8.44% | SUE: 0.08 | # QB: 0
Additional Sources for QDEL Stock
Tweets: X | Stocktwits
Fund Manager Positions: Dataroma | Stockcircle